For the quarter ended March 2024, ArcBest (ARCB - Free Report) reported revenue of $1.04 billion, down 6.3% over the same period last year. EPS came in at $1.34, compared to $1.58 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.03 billion, representing a surprise of +0.97%. The company delivered an EPS surprise of -12.99%, with the consensus EPS estimate being $1.54.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how ArcBest performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Asset-Light - Operating Ratio (Non-GAAP): 101.2% compared to the 100.2% average estimate based on two analysts.
- Asset-Based - Operating Ratio (Non-GAAP): 92% versus 91.8% estimated by two analysts on average.
- Revenues- Asset-Based: $671.47 million versus the four-analyst average estimate of $660.94 million. The reported number represents a year-over-year change of -3.8%.
- Revenues- Asset-Light: $396.36 million versus $392.26 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -9.5% change.
- Revenues- Other and eliminations: -$31.41 million versus the three-analyst average estimate of -$30.61 million. The reported number represents a year-over-year change of +5.4%.
- Operating income Non-GAAP- Other and eliminations: -$6.07 million versus -$6 million estimated by two analysts on average.
- Operating income Non-GAAP- Asset-Based: $53.46 million versus the two-analyst average estimate of $56.41 million.
View all Key Company Metrics for ArcBest here>>>Shares of ArcBest have returned -8.9% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
For the quarter ended March 2024, ArcBest (ARCB - Free Report) reported revenue of $1.04 billion, down 6.3% over the same period last year. EPS came in at $1.34, compared to $1.58 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.03 billion, representing a surprise of +0.97%. The company delivered an EPS surprise of -12.99%, with the consensus EPS estimate being $1.54.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how ArcBest performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Asset-Light - Operating Ratio (Non-GAAP): 101.2% compared to the 100.2% average estimate based on two analysts.
- Asset-Based - Operating Ratio (Non-GAAP): 92% versus 91.8% estimated by two analysts on average.
- Revenues- Asset-Based: $671.47 million versus the four-analyst average estimate of $660.94 million. The reported number represents a year-over-year change of -3.8%.
- Revenues- Asset-Light: $396.36 million versus $392.26 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -9.5% change.
- Revenues- Other and eliminations: -$31.41 million versus the three-analyst average estimate of -$30.61 million. The reported number represents a year-over-year change of +5.4%.
- Operating income Non-GAAP- Other and eliminations: -$6.07 million versus -$6 million estimated by two analysts on average.
- Operating income Non-GAAP- Asset-Based: $53.46 million versus the two-analyst average estimate of $56.41 million.
View all Key Company Metrics for ArcBest here>>>Shares of ArcBest have returned -8.9% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on ARCB - FREE